Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04155 (
pS2
)
1,234
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have compared the DNase I hypersensitivity of the regulatory region of two estrogen-regulated genes,
pS2
and cathepsin D in hormone-dependent and -independent breast carcinoma cell lines. This strategy allowed the identification of two important control regions, one in
pS2
and the other in cathepsin D genes. In the hormone-dependent MCF7 cell line, within the
pS2
gene 5'-flanking region, we detected two major DNase I hypersensitive sites, induced by estrogens and/or IGFI:
pS2
-HS1, located in the proximal promoter and
pS2
-HS4, located -10.5 Kb from the
CAP
site, within a region that has not been cloned. The presence of these two DNase I hypersensitive sites correlates with
pS2
expression. Interestingly in MCF7 cells, estrogens and IGFI induced indistinguishable chromatin structural changes over the
pS2
regulatory region, suggesting that the two transduction-pathways converge to a unique chromatin target. In two cell lines that do not express
pS2
, MDA MB 231, a hormone-independent cell line that lacks the estrogen receptor alpha, and HE5, a cell line derived from MDA MB 231 by transfection that expresses estrogen receptor alpha, there was only one hormone-independent DNase I hypersensitive site. This site,
pS2
-HS2, was located immediately upstream of
pS2
-HS1. In MCF7 cells, two major DNase I hypersensitive sites were present in the 5'-flanking sequences of the cathepsin D gene, which is regulated by estrogens in these cells. These sites, catD-HS2 and catD-HS3, located at positions -2.3 Kb and -3.45 Kb, respectively, were both hormone-independent. A much weaker site, catD-HS1, covered the proximal promoter. In MDA MB 231 cells, that express cathepsin D constitutively, we detected an additional strong hormone-independent DNase I hypersensitive site, catD-HS4, located at position -4.3 Kb. This region might control the constitutive over-expression of cathepsin D in hormone-independent breast cancer cells. All together, these data demonstrate that a local reorganization of the chromatin structure over
pS2
and cathepsin D promoters accompanies the establishment of the hormone-independent phenotype of the cells.
...
PMID:Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines. 992 10